NVO vs. JPM
NVO (Novo Nordisk A/S) and JPM (JPMorgan Chase & Co.) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while JPM operates in Banks - Diversified (Financial Services). Over the past 10 years, NVO returned 8.18%/yr vs 21.27%/yr for JPM. At a 0.20 correlation, their price movements are largely independent.
Performance
NVO vs. JPM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a 0.91% return, which is significantly lower than JPM's 6.66% return. Over the past 10 years, NVO has underperformed JPM with an annualized return of 8.18%, while JPM has yielded a comparatively higher 21.27% annualized return.
NVO
- 1D
- -1.41%
- 1M
- 14.86%
- 6M
- -17.63%
- YTD
- 0.91%
- 1Y
- -19.26%
- 3Y*
- -13.51%
- 5Y*
- 4.43%
- 10Y*
- 8.18%
- ALL TIME*
- 14.52%
JPM
- 1D
- -0.65%
- 1M
- 4.67%
- 6M
- 9.49%
- YTD
- 6.66%
- 1Y
- 18.57%
- 3Y*
- 32.69%
- 5Y*
- 20.23%
- 10Y*
- 21.27%
- ALL TIME*
- 12.35%
NVO vs. JPM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 0.91% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
JPM JPMorgan Chase & Co. | 6.66% | 37.27% | 44.29% | 30.63% | -12.64% | 27.75% | -5.53% | 47.26% | -6.62% | 26.76% |
Correlation
The correlation between NVO and JPM is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Dec 30, 1983 | 0.20 |
The correlation between NVO and JPM shifts across timeframes, from 0.16 (10 years) to 0.27 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
NVO:
$220.46B
JPM:
$908.01B
NVO:
DKK 27.42
JPM:
$23.29
NVO:
11.83
JPM:
14.55
NVO:
0.51
JPM:
1.61
NVO:
4.40
JPM:
3.18
NVO:
7.11
JPM:
2.68
NVO:
DKK 327.80B
JPM:
$297.63B
NVO:
DKK 268.30B
JPM:
$186.33B
NVO:
DKK 181.54B
JPM:
$90.84B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. JPM — Risk / Return Rank
NVO
JPM
NVO vs. JPM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and JPMorgan Chase & Co. (JPM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | JPM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.22 | ||
| Sortino ratioReturn per unit of downside risk | -1.44 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.16 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | -0.39 | 1.21 | -1.60 |
| Martin ratioReturn relative to average drawdown | -0.61 | 2.85 | -3.46 |
Loading charts...
Drawdowns
NVO vs. JPM - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, roughly equal to the maximum JPM drawdown of -76.16%. Use the drawdown chart below to compare losses from any high point for NVO and JPM.
Loading charts...
Drawdown Indicators
| NVO | JPM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -76.16% | +1.46% |
Max Drawdown (1Y)Largest decline over 1 year | -49.17% | -15.47% | -33.70% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -24.42% | -50.28% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -38.77% | -35.93% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | -43.63% | -31.07% |
Current DrawdownCurrent decline from peak | -63.95% | -2.32% | -61.63% |
Average DrawdownAverage peak-to-trough decline | -17.89% | -17.58% | -0.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.75% | 6.53% | +25.22% |
Volatility
NVO vs. JPM - Volatility Comparison
Novo Nordisk A/S (NVO) has a higher volatility of 9.48% compared to JPMorgan Chase & Co. (JPM) at 6.42%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than JPM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | JPM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.48% | 6.42% | +3.06% |
Volatility (6M)Calculated over the trailing 6-month period | 37.43% | 16.66% | +20.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.79% | 22.17% | +29.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.58% | 24.41% | +14.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.63% | 27.31% | +5.32% |
Dividends
NVO vs. JPM - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 3.63%, more than JPM's 1.77% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JPM JPMorgan Chase & Co. | 1.77% | 1.72% | 1.92% | 2.38% | 2.98% | 2.34% | 2.83% | 2.37% | 2.54% | 1.91% | 2.13% | 2.54% |
NVO Novo Nordisk A/S | 3.63% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NVO vs. JPM - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and JPMorgan Chase & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVO vs. JPM - Profitability Comparison
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
JPM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, JPMorgan Chase & Co. reported a gross profit of 54.83B and revenue of 82.46B. Therefore, the gross margin over that period was 66.5%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
JPM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, JPMorgan Chase & Co. reported an operating income of 27.52B and revenue of 82.46B, resulting in an operating margin of 33.4%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
JPM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, JPMorgan Chase & Co. reported a net income of 21.16B and revenue of 82.46B, resulting in a net margin of 25.7%.
Frequently Asked Questions
NVO and JPM have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (9.48%) compared to JPM (6.42%). In terms of maximum drawdown, NVO dropped -74.70% vs JPM's -76.16%.
JPM currently has the higher Sharpe Ratio (0.84 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVO and JPM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer